Clarify Whether Omega-3s Have Cardiovascular Benefits

Do omega-3 fatty acid supplements reduce CV risk?

Mounting evidence suggests they don't...despite prior evidence with Rx Vascepa (icosapent ethyl), a form of EPA (eicosapentaenoic acid).

Vascepa 2 g BID is approved to reduce CV risk in some high-risk patients with moderately elevated triglycerides despite statins.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote